论文部分内容阅读
变应性鼻炎(allergic rhinitis,AR)是一种由IgE介导的鼻黏膜非感染性慢性炎性疾病~([1]),严重影响患者的工作、生活、学习及生存质量,治疗不及时或不合理还会诱发哮喘。据统计,全球约有4亿人口饱受AR的困扰,给患者、国家和社会带来了巨大的经济负担。而AR患者的生存质量研究也成为了近年来国内外学者、专家研究的热点问题。生存质量(quality of life,QOL)这一概念最早是在美国经济学家J.K.加尔布雷思所著的《富裕
Allergic rhinitis (AR) is a noninfectious, chronic inflammatory disease of the nasal mucosa mediated by IgE (1), which seriously affects the work, living, learning and quality of life of patients, and the treatment is not timely Or unreasonable will also induce asthma. According to statistics, about 400 million people in the world are plagued by AR and bring enormous financial burden to patients, the country and society. The quality of life of patients with AR research has become a hot issue at home and abroad in recent years, scholars and experts. The concept of quality of life (QOL) was first described by J.K. Galbraith, American economist